$DXCM News

Why Is DexCom (DXCM) In Focus After Its G7 Trial Reached NEJM?

DexCom: The 15-Day Sensor Lowered The Cost Curve Before The Type 2 Wave Arrives

NEJM study supports CGM use for people with diabetes who don’t take insulin

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

DexCom's CONNECT Study Published In The New England Journal Of Medicine; Findings Support The Role Of CGM Earlier In Type 2 Diabetes Care For All People, Including Those Over The Age Of 65

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation

Here's What to Expect From DexCom’s Next Earnings Report

BTIG Maintains Buy on DexCom, Raises Price Target to $96

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time

Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup

RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Dexcom Becomes Team Novo Nordisk's Official CGM Partner, Releases Report Citing Three Type 2 Care Challenges Across Eight Countries

DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow

Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?

DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer

Truist Securities Maintains Buy on DexCom, Raises Price Target to $102